Wolters Kluwer to buy AgileMD for up to $100 million
Wolters Kluwer Health agreed on November 13 to acquire AgileMD, a San Francisco company whose software puts care guidelines and an AI clinical surveillance tool inside hospital EHRs, for up to $100 million.
Docket, covering health regulation and AI in care
, 2 min read
$100MMaximum price, with $40M paid upfront
What to know
- Wolters Kluwer will pay $40 million upfront and up to $60 million more if AgileMD hits performance targets.
- AgileMD makes Pathways, which builds local care guidelines into the EHR, and eCART, which the release calls an FDA-cleared, AI-powered clinical surveillance engine.
- The deal is expected to close in the first quarter of 2027 or sooner, pending customary conditions and government approvals.
Wolters Kluwer Health, the medical information unit of Dutch publisher Wolters Kluwer, has agreed to buy AgileMD, a San Francisco clinical decision support company, for up to $100 million. The company announced the deal on November 13 from Alphen aan den Rijn in the Netherlands. The details below come from Wolters Kluwer's release; no independent report with further terms was available at publication.
The terms
Wolters Kluwer will pay $40 million in cash at closing. The rest, up to $60 million more, is deferred and depends on AgileMD meeting performance targets. The company expects the deal to close in the first quarter of 2027 or sooner, subject to customary closing conditions and government approvals.
AgileMD is small. It was founded in 2011, has 23 employees, all of whom will join Wolters Kluwer Health, and expects about $7 million in annual recurring revenue by the end of 2026, according to the release. Wolters Kluwer said it expects the deal to have an immaterial effect on its adjusted earnings and to return at least its 8% after-tax cost of capital within three to five years. AgileMD's co-founders are chief executive Borna Safabakhsh and chief medical officer Dana Edelson, M.D.
What AgileMD sells
The company has two products, as the release describes them:
- Pathways turns a hospital's own clinical guidelines into step-by-step prompts inside the electronic health record (EHR), so clinicians see the local protocol while they work.
- eCART is a real-time, AI-powered clinical surveillance engine. Wolters Kluwer describes it as FDA-cleared and designed to help reduce mortality among patients it monitors. The release does not give a 510(k) number, and it does not name AgileMD's hospital customers.
FDA clearance means the agency found the software substantially equivalent to a device already on the market. It is a lower bar than approval; our explainer on FDA clearance, approval and De Novo covers the difference.
Where it fits at Wolters Kluwer
Wolters Kluwer already owns UpToDate, the point-of-care reference many clinicians use to look up diagnosis and treatment guidance. Its release says the UpToDate Expert AI tool has been adopted by more than 2,700 U.S. hospitals and health systems. Buying AgileMD adds software that acts on patient data inside the EHR, not only reference content that clinicians search.
The deal is the second health software acquisition this week aimed at the clinician's workflow inside the record. On November 11, Inovalon agreed to buy e-prescribing company DrFirst. Earlier in the week, smart-ring maker Oura said it would acquire AI primary care startup Counsel Health.
Why it matters
This deal moves an FDA-cleared AI surveillance tool into the portfolio of a company whose reference tools already sit in thousands of hospitals. Whether that spreads the tool widely will depend on hospitals choosing to turn it on, and on evidence that its alerts improve outcomes. A recent study found that among FDA-cleared AI devices that received algorithm updates, 86% reported no clinical benefit data, a gap hospitals buying these tools face.
This article is general information about how technology works. It is not medical advice. Talk to a clinician about your own health.
Sources
- Wolters Kluwer to acquire AI-powered clinical decision support platform AgileMD, Wolters Kluwer via GlobeNewswire (Yahoo Finance), November 13, 2026
Digital health and AI in careFDA and health regulation
Written by an AI correspondent under standards set by editor Jacob Knight. Spotted an error? Tell us and we will fix it.